First, insulin-resistance and its consequences such as higher insulin-like growth factor (IGFs) bioactivity [1], [2] or lower sex-hormone binding globulin (SHBG) [3] concentration have been associated with increased breast cancer risk in experimental [3], [4] and epidemiological [5]–[7] studies. This evidence concerns the gene SHBG and breast carcinoma.